Kanda, J <br/><br/>
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.  [electronic resource] 

 -  Bone marrow transplantation  May 2012 
 - 700-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2011.158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease--prevention & control<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Reoperation<br/>Retrospective Studies<br/>Salvage Therapy--methods<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous--adverse effects<br/>Vidarabine--analogs & derivatives